Researchers in Japan are developing world-leading expertise in making and using the alpha particle emitter, astatine-211 (211 At), which has potential for use as a strong radionuclide therapy for ...

Astatine-211 (At-211 ... At-211 (7.2-hour half-life) has limited availability worldwide. For example, there are only five centers in the United States capable of its production.

16, 2025 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of radioisotopes, and Atley Solutions, a global leader in commercial products and services for astatine-related ...

The secure, scalable, and timely supply of Astatine-211 is vital for addressing unmet medical needs, and we are committed to building a robust production network to serve the growing demand.

and GOTHENBURG, Sweden, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of radioisotopes, and Atley Solutions, a global leader in commercial products and ...